Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 0 | 37 |
| Gross Profit | N/A | N/A | N/A | N/A | 37 |
| Operating Expenses | 153,484 | 194,485 | 144,391 | 131,993 | 135,338 |
| Operating Income | -153,430 | -194,485 | -144,391 | -131,993 | -135,301 |
| Interest Expense | 1,004 | 1,031 | 1,051 | 1,073 | 1,096 |
| Other Income | -1,175 | -796 | -653 | 14,649 | 14,236 |
| Pre-tax Income | -155,609 | -196,312 | -146,095 | -118,417 | -122,161 |
| Net Income Continuous | -155,609 | -196,312 | -146,095 | -118,417 | -122,161 |
| Net Income | $-155,609 | $-196,312 | $-146,095 | $-118,417 | $-122,161 |
| EPS Basic Total Ops | -2.55 | -3.21 | -2.40 | -1.98 | -2.09 |
| EPS Basic Continuous Ops | -2.55 | -3.21 | -2.40 | -1.98 | -2.10 |
| EPS Diluted Total Ops | -2.55 | -3.21 | -2.40 | -1.98 | -2.09 |
| EPS Diluted Continuous Ops | -2.55 | -3.21 | -2.40 | -1.98 | -2.10 |
| EPS Diluted Before Non-Recurring Items | -2.54 | -3.21 | -2.40 | -1.98 | -2.10 |
| EBITDA(a) | $-151,503 | $-192,518 | $-142,307 | $-129,906 | $-133,208 |